Stockscreener 앱 받기
5.14
7.05%
-0.39
시간 외 거래:
5.14
전일 마감가:
$5.53
열려 있는:
$5.51
하루 거래량:
274.25K
Relative Volume:
0.44
시가총액:
$136.82M
수익:
$50.14M
순이익/손실:
$-35.38M
주가수익비율:
-3.6714
EPS:
-1.4
순현금흐름:
$-39.46M
1주 성능:
-7.22%
1개월 성능:
+23.26%
6개월 성능:
-40.44%
1년 성능:
-48.03%
1일 변동 폭
$5.02
$5.51
1주일 범위
$5.02
$5.615
52주 변동 폭
$3.60
$14.16
Avita Medical Inc Stock (RCEL) Company Profile
명칭
Avita Medical Inc
전화
661-568-1317
주소
28159 AVENUE STANFORD, VALENCIA, CA
RCEL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RCEL
Avita Medical Inc
|
5.14 | 149.41M | 50.14M | -35.38M | -39.46M | -1.40 |
|
ABT
Abbott Laboratories
|
132.57 | 232.02B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
95.41 | 144.14B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
364.60 | 141.53B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.45 | 123.78B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
73.94 | 44.14B | 5.69B | 1.41B | 577.90M | 6.9828 |
Avita Medical Inc Stock (RCEL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-08 | 다운그레이드 | BTIG Research | Neutral → Sell |
| 2024-12-24 | 개시 | D. Boral Capital | Buy |
| 2024-04-11 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2023-06-27 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-03-02 | 개시 | Piper Sandler | Overweight |
| 2020-08-27 | 개시 | BofA Securities | Buy |
| 2020-04-21 | 개시 | Oppenheimer | Outperform |
| 2020-03-03 | 개시 | BTIG Research | Buy |
모두보기
Avita Medical Inc 주식(RCEL)의 최신 뉴스
Applying sector rotation models to AVITA Medical Inc.2025 Buyback Activity & Expert Verified Stock Movement Alerts - newser.com
AVITA Medical Inc. stock trend forecastSell Signal & High Win Rate Trade Tips - newser.com
Real time social sentiment graph for AVITA Medical Inc.July 2025 Weekly Recap & Community Supported Trade Ideas - newser.com
Why AVITA Medical Inc. stock remains resilient2025 Dividend Review & Technical Entry and Exit Alerts - newser.com
Using economic indicators to assess AVITA Medical Inc. potentialBond Market & Short-Term Trading Opportunity Alerts - newser.com
What technical models suggest about AVITA Medical Inc.’s comebackMarket Sentiment Report & AI Based Trade Execution Alerts - newser.com
Smart tools for monitoring AVITA Medical Inc.’s price actionJuly 2025 Update & Technical Pattern Alert System - newser.com
Will AVITA Medical Inc. stock recover faster than peers2025 Market WrapUp & Long-Term Capital Growth Strategies - newser.com
Weiss Ratings Reaffirms Sell (D-) Rating for Avita Medical (NASDAQ:RCEL) - MarketBeat
AVITA REMINDER: Bragar Eagel & Squire, P.C. Reminds AVITA - GlobeNewswire
MAREX REMINDER: Bragar Eagel & Squire, P.C. Reminds Marex Group Investors to Contact the Firm Regarding Ongoing Investigation on Behalf of Marex Stockholders - GlobeNewswire Inc.
How to interpret RSI for AVITA Medical Inc. stockJuly 2025 Decliners & Advanced Technical Signal Analysis - newser.com
Custom strategy builders for tracking AVITA Medical Inc.Trade Entry Report & Free Low Drawdown Momentum Trade Ideas - newser.com
What drives AVITA Medical Inc stock priceStraddle and Strangle Trades & Bull Bear Market Updates - earlytimes.in
Understanding AVITA Medical Inc.’s price movementJuly 2025 Weekly Recap & Advanced Swing Trade Entry Plans - newser.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AVITA Medical, Inc.RCEL - Eastern Progress
RCEL: Kirby McInerney LLP Continues Securities Investigation on Behalf of AVITA Medical, Inc. Investors - ACCESS Newswire
AVITA (RCEL) INVESTIGATION ALERT: Bragar Eagel & Squire, - GlobeNewswire
Upcoming Events - FinancialContent
AVITA Medical, Inc. (NASDAQ:RCEL) Surges 28% Yet Its Low P/S Is No Reason For Excitement - simplywall.st
Combining machine learning predictions for AVITA Medical Inc.Profit Target & Free Growth Oriented Trading Recommendations - newser.com
Applying Wyckoff theory to AVITA Medical Inc. stock2025 Momentum Check & Expert Curated Trade Ideas - newser.com
Avita Medical's RECELL System Secures CMS Reimbursement for Acute Wound Care - MarketScreener
CMS New Technology Add-On Payment Expands Access to RECELL® for Patients with Non-Burn Acute Wounds - Investing News Network
AVITA Medical (RCEL) Secures NTAP Reimbursement for RECELL - GuruFocus
Securities Fraud Investigation Into AVITA Medical, Inc. - GlobeNewswire
Securities Fraud Investigation Into AVITA Medical, Inc. (RCEL) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz - GlobeNewswire
What to expect from AVITA Medical Inc. in the next 30 daysJuly 2025 Weekly Recap & Free Daily Entry Point Trade Alerts - newser.com
Market reaction to AVITA Medical Inc.’s recent news2025 Stock Rankings & Precise Swing Trade Entry Alerts - newser.com
What analysts say about Melco International Development Limited MX7A stockSector Rotation Strategies & Free Risk Assessment and Control - earlytimes.in
Avita Medical Inc. (NASDAQ:RCEL) Given Average Rating of "Hold" by Analysts - MarketBeat
AVITA Medical, Inc. (NASDAQ:RCEL): Is Breakeven Near? - 富途牛牛
AVITA INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is - GlobeNewswire
AVITA INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating AVITA Medical, Inc. - Bluefield Daily Telegraph
Avita Medical Inc (RCEL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Avita Medical Inc 주식 (RCEL) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| O'Toole David D | CFO |
Aug 26 '25 |
Buy |
4.52 |
2,000 |
9,040 |
31,657 |
| McNamara Robert | Director |
Aug 19 '25 |
Buy |
5.00 |
10,000 |
50,000 |
76,771 |
| O'Toole David D | CFO |
Aug 12 '25 |
Buy |
4.81 |
2,000 |
9,620 |
29,657 |
| McNamara Robert | Director |
Mar 06 '25 |
Buy |
8.30 |
11,000 |
91,300 |
56,749 |
| McNamara Robert | Director |
Feb 20 '25 |
Buy |
10.09 |
10,000 |
100,900 |
45,749 |
| O'Toole David D | CFO |
Feb 20 '25 |
Buy |
9.90 |
1,000 |
9,900 |
25,734 |
| O'Toole David D | CFO |
Feb 19 '25 |
Buy |
10.25 |
1,000 |
10,250 |
24,734 |
| Crowe Suzanne | Director |
Dec 09 '24 |
Buy |
13.15 |
486 |
6,391 |
36,912 |
| O'Toole David D | CFO |
Dec 05 '24 |
Buy |
12.46 |
975 |
12,152 |
23,734 |
1.83%
자본화:
|
볼륨(24시간):